Common and dissociable effects of oxytocin and lorazepam on the neurocircuitry of fear

Autor: Dirk Scheele, Tony Stöcker, René Hurlemann, Torge Dellert, Mari Babasiz, Ulrich Ettinger, Angela Herscheid, Laura Remmersmann, Juergen Hennig, Johannes Schultz, Ann-Kathrin Kreuder, Nina Marsh, Alexandra Philipsen, Ruediger Stirnberg

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America 117(21), 11781-11787 (2020). doi:10.1073/pnas.1920147117
Proc Natl Acad Sci U S A

Benzodiazepines (BZDs) represent the gold standard of anxiolytic pharmacotherapy; however, their clinical benefit is limited by side effects and addictive potential. Consequently, there is an urgent need to develop novel and safe anxiolytics. The pep

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70047d77fd24ce3729a5e3fdb66bf917
https://doi.org/10.1073/pnas.1920147117